Refine Search

New Search

Result: 1

(searched for: A Case of Hemophagocytic Lymphohistiocytosis Induced by Regorafenib)
Save to Scifeed
Page of 1
Articles per Page
by
Show export options
  Select all
Marion Jaffrelot, Noémie Gadaud, Jean-Pierre Delord, Carlos Gomez-Roca, Sarah Bétrian
Archives of Clinical and Medical Case Reports, Volume 5, pp 96-100; doi:10.26502/acmcr.96550332

Abstract:
Hemophagocytic lymphohistiocytosis (HLH) is a rare and severe condition of immune dysregulation characterized by severe organ damage induced by a hyperinflammatory response and uncontrolled T-cell and macrophage activation. Secondary HLH, also known as macrophage activation syndrome, commonly presents in adulthood and characterized by acquired immune dysfunction in response to infections, malignancies, or autoinflammatory/autoimmune disorders. Secondary HLH induced by regorafenib has not been yet described. Here we report a case of HLH induced by regorafenib, confirmed by clinical, laboratory and histopathological findings, with typical results on bone marrow aspiration.
Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top